WHO ICTRP trial

Open-label Study to Evaluate the EULAR-RAID Score, Rheumatoid Arthritis Impact…

EUCTR2007-007888-24-FR · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2007-007888-24-FR
Public title Open-label Study to Evaluate the EULAR-RAID Score, Rheumatoid Arthritis Impact of Disease Score, in Rheumatoid Arthritis Patients Eligible to Etanercept and Who Will Receive Etanercept. - RAINBOW
Scientific title Open-label Study to Evaluate the EULAR-RAID Score, Rheumatoid Arthritis Impact of Disease Score, in Rheumatoid Arthritis Patients Eligible to Etanercept and Who Will Receive Etanercept. - RAINBOW
Primary sponsor Wyeth Pharmaceuticals France
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes
Countries France
Conditions RHEUMATOID ARTHRITIS
Interventions Trade Name: ENBREL Pharmaceutical Form: Injection* INN or Proposed INN: ETANERCEPT CAS Number: 185243690 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 50-
Registration date Jul 17, 2008
Target size 101
Secondary IDs 0881X1-4508-FR
Registry page clinicaltrialsregister.eu

At a glance

  • Yes Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations